HBIO

시간 외 거래: 5.48 -0.12 -2.14%

Harvard Bioscience Inc (HBIO)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

Harvard Bioscience Inc Stock (HBIO) Company Profile

Harvard Bioscience Inc

Healthcare (1114)

(508) 893-8999

84 OCTOBER HILL RD, HOLLISTON, MA

최신 SEC 제출 서류

HBIO's Discussions on Twitter

Compare HBIO vs ISRG, BDX, ALC, MDLN, RMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
HBIO Harvard Bioscience Inc	5.60	215.60M	86.55M	-56.70M	4.87M	-1.2845
ISRG Intuitive Surgical Inc	479.93	169.66B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	156.53	44.97B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	75.01	36.92B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	43.59	34.30B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	227.41	33.20B	5.40B	1.49B	1.78B	10.12

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-04-09	다운그레이드	KeyBanc Capital Markets	Overweight → Sector Weight
2023-03-10	업그레이드	The Benchmark Company	Speculative Buy → Buy
2021-01-07	업그레이드	The Benchmark Company	Speculative Buy → Buy
2020-12-09	개시	Northland Capital	Outperform
2020-11-10	개시	KeyBanc Capital Markets	Overweight
2019-07-08	다운그레이드	Janney	Buy → Neutral
2018-01-24	재확인	Janney	Buy
2018-01-23	재확인	The Benchmark Company	Buy
2016-11-17	개시	Singular Research	Buy
2015-07-28	개시	The Benchmark Company	Buy

Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스

Harvard Bioscience Inc (HBIO) 재무 분석

Harvard Bioscience Inc (HBIO)

Harvard Bioscience Inc Stock (HBIO) Company Profile

Compare HBIO vs ISRG, BDX, ALC, MDLN, RMD

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스

Insider Buying: Stephen Denelsky Acquires 10,000 Shares of Harva - GuruFocus

Harvard Bioscience (HBIO) director Denelsky buys $48,700 in shares By Investing.com - Investing.com India

Harvard Bioscience (HBIO) director Denelsky buys $48,700 in shares - Investing.com

Harvard Bioscience (HBIO) director buys 10,000 shares in open market - Stock Titan

Harvard Bioscience director Snider buys $103,603 in HBIO stock - Investing.com

Harvard Bioscience (HBIO) director buys 21,000 shares on open market - Stock Titan

Layoff Watch: What are analysts price targets for Harvard Bioscience IncTrade Analysis Report & Real-Time Market Sentiment Alerts - baoquankhu1.vn

Insider Buying: John Duke Acquires 5,000 Shares of Harvard Biosc - GuruFocus

Harvard Bioscience CEO Duke buys $25k in shares - Investing.com

Harvard Bioscience (HBIO) CEO adds shares and holds major RSU awards - Stock Titan

Harvard Bioscience at KeyBanc Forum: Strategic Growth and Market Focus By Investing.com - Investing.com Canada

Harvard Bioscience outlines 2026 guidance with 2%–4% revenue growth and high-margin focus following structural improvements - MSN

Harvard Bioscience 2026 Investor Overview: Translational Science Tools, Growth Strategy, and Financial Outlook - Minichart

Harvard Bioscience (HBIO) Earnings Transcript - AOL.com

Harvard Bioscience Highlights CFO Appointment and Strategic Repositioning - TipRanks

Market Trends: Whats next for Harvard Bioscience Inc stockRisk Management & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn

Harvard Bioscience provides investor presentation; FY25 results, FY26 guidance and strategic actions - TradingView

Harvard Bioscience (NASDAQ: HBIO) posts FY25 metrics and guides modest 2026 growth - Stock Titan

HBIO: Benchmark Raises Price Target to $6.00, Maintains Speculat - GuruFocus

Benchmark raises Harvard Bioscience stock price target to $6 on reverse split By Investing.com - Investing.com South Africa

Benchmark raises Harvard Bioscience stock price target to $6 on reverse split - Investing.com

How The Harvard Bioscience (HBIO) Investment Narrative Is Resetting After Lower 2026 Expectations - Yahoo Finance

Benchmark cuts Harvard Bioscience stock price target on NIH concerns - Investing.com Nigeria

HBIO: Analyst Bruce D. Jackson Maintains Rating but Lowers Price Target | HBIO Stock News - GuruFocus

Benchmark cuts Harvard Bioscience stock price target on NIH concerns By Investing.com - Investing.com South Africa

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2025 Earnings Call Transcript - Insider Monkey

Harvard Bioscience 2025 10‑K: Revenue $86.6M, Gross Profit $49.91M - TradingView

Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high By Investing.com - Investing.com Canada

HBIO Stock Price, Quote & Chart | HARVARD BIOSCIENCE INC (NASDAQ:HBIO) - ChartMill

Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high - Investing.com

Harvard Bioscience, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:HBIO) 2026-03-13 - Seeking Alpha

Harvard Bioscience Q4 2025 Earnings Call Transcript - MarketBeat

Harvard Bioscience, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com

Harvard Bioscience Inc (HBIO) Q4 2025 Earnings Call Highlights: - GuruFocus

Harvard Bioscience, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2026 - marketscreener.com

Earnings Call Summary | Harvard Bioscience(HBIO.US) Q4 2025 Earnings Conference - 富途牛牛

Harvard Bioscience, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Harvard Bioscience: Q4 Earnings Snapshot - Chron

Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth By Investing.com - Investing.com Nigeria

Harvard Bioscience earnings missed by $0.10, revenue topped estimates - Investing.com Canada

Earnings call transcript: Harvard Bioscience Q4 2025 shows revenue growth - Investing.com UK

Harvard Bioscience Q4 & Annual Financial Results 2025News and Statistics - IndexBox

Harvard Bioscience (HBIO) Reports Q4 Loss of $0.06/Share, Revenue Falls 3.3% to $23.7M - AlphaStreet

HBIO Projects Robust EBITDA Growth for 2026 - GuruFocus

Harvard Bioscience (HBIO) Reports Slight Dip in Q4 Revenue as St - GuruFocus

HBIO Projects Adjusted EBITDA Growth for Upcoming Period - GuruFocus

Harvard Bioscience: Fourth Quarter Financial Results Overview - Bitget

Harvard Bioscience Reports Q4 Revenue $23.7M, FY2025 Revenue $86.6M and Improved Gross Margins - TradingView

HARVARD BIOSCIENCE ($HBIO) Releases Q4 2025 Earnings - Quiver Quantitative

Harvard Bioscience Q4 revenue falls 3%, reports net loss - TradingView

Harvard Bioscience : Q4 2025 Harvard Bioscience, Inc. Earnings Conference Call - marketscreener.com

Harvard Bioscience Inc (HBIO) 재무 분석

매출

순이익

현금흐름

주당 순 이익

HBIO과 유사한 종목